The GPR133 receptor is expressed by osteoblasts, the cells that make bone. The study suggests that this receptor helps those cells sense two kinds of input: mechanical strain and signals relayed by ...

GLP-1s are linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity, new research suggests, though an additional study also points to better ...

Treatment with GLP-1 RAs for T2D and obesity is associated with increased risk for osteoporosis, gout, and osteomalacia compared with nonuse.

Dublin, OH / Syndication Cloud / March 15, 2026 / SPRY 365 The Postmenopausal Bone Loss Crisis Every year after ...

Gina Woods, MD, shares three case scenarios of sequential treatment decision-making for long-term therapy and discusses research that can inform clinical decisions.

People who take GLP-1 medications for several years may face a higher risk of developing osteoporosis, gout, and osteomalacia, according to new research presented Monday at the an ...

Recent studies show GLP-1s tied higher osteoporosis risk, with variations by diabetes status and weight changes in large patient datasets.

New study suggests GLP-1 drugs like Ozempic and Wegovy may raise fracture risk by 11% in adults 65 and older with type 2 ...

Certain foods can cause your body to lose the calcium it needs for bone strength. Learn which foods to limit to help protect ...

John “Gabe” Horneff, an orthopedic surgeon at Pennsylvania Hospital, had noticed a peculiar trend: Some patients taking GLP-1s would come in with significant tendon injuries from relatively minor ...

People on GLP-1s had slightly higher risks of osteoporosis and gout than similar people not taking these drugs. But diet and ...

GLP-1 drugs — including Ozempic and Wegovy — may be tied to a slightly higher risk of osteoporosis and gout, according to research presented Monday at the American Academy of Orthopaedic Surgeons’ ...